Rapid antimicrobial susceptibility testing (AST) on the front line

13 October 2020

In this video, Duncan Porter, Senior Director and leader of the Clinical Microbiology segment at Thermo Fisher Scientific, describes the power of rapid antimicrobial susceptibility testing (AST) to not only provide timely, actionable results in a single shift , but form a fundamental part of antibiotic stewardship. Porter illustrates how the time to targeted therapy is key to recovery for critically ill patients, and by adopting rapid AST, clinicians can access information around the correct therapy sooner. 

This video is the first installment in our four-part series exploring the diagnostic labs of the future. Follow the links below for the complete series:

  1. Rapid antimicrobial susceptibility testing (AST) on the front line
  2. How the COVID-19 outbreak is reshaping the diagnostics industry
  3. Shaping the future of the UK diagnostics industry while ensuring continuity of supply
  4. From qPCR to serology testing: Discover how scientists are keeping up with COVID-19